With more than 1900 full-time faculty, $302 million in research awards and more than 500,000 square feet of dedicated research space, IU School of Medicine is well-equipped to take on bold medical research projects that promote groundbreaking scientific discovery while improving health care interventions, patient care and health outcomes.
In the most recent fiscal year, IU School of Medicine received nearly $320 million in total research grants and awards, including $126 million from the National Institutes of Health. Anantha Shekhar, MD, PhD, executive associate dean for Research Affairs, oversees IU School of Medicine’s research enterprise. He also has served as the founding director of the Indiana Clinical and Translational Sciences Institute since 2008.
Precision Health Initiative
What is the Precision Health Initiative?
Transforming Clinical Practices Initiative
Medical Research Expertise
IU School of Medicine investigators conduct world-class basic, translational and clinical research in a broad range of scientific endeavors. Neuroscience, cancer, musculoskeletal and diabetes/cardiovascular/metabolic disorders have been designated as research priority areas and represent the school’s areas of expertise. Strategic themes within each of those priority areas are precision medicine, population health, cell-based therapy and life-span research.
Always Something New
With more than $300 million in external grants and awards, IU School of Medicine oversees a comprehensive research enterprise guided by the following goals:
- Grow research funding through focused investment
- Recruit and retain research leaders, both physicians and research scientists
- Enhance the health of Indiana and beyond by offering innovative therapies not available elsewhere and being a leader in population health management
- Accelerate translation of research to the clinic and the marketplace through high-quality clinical trials and public-private partnerships
- Train future researchers for Indiana and worldwide
- Researchers learn dangerous brain parasite ‘orders in’ for dinner
- Study based at Indiana University School of Medicine finds improvements in insulin production wane after treatment stops in adults with early type 2 diabetes
- Immunotherapy delays Type 1 diabetes diagnosis in people at high risk
- Study finds link between kidney injury, neurocognitive impairment in children with malaria
- Clinical trial at IU School of Medicine improves treatment of genetic rickets